Two Sigma Investments
RVLP

Two Sigma Investments’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Two Sigma Investments’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22,413
Closed -$30K – 2944
2022
Q2 		$30K Sell
22,413
-64,524
-74% -$93.5K ﹤0.01% 2379
2022
Q1 		$147K Sell
86,937
-162,914
-65% -$233K ﹤0.01% 2382
2021
Q4 		$270K Buy
+249,851
New +$405K ﹤0.01% 3717
2020
Q2 		– Sell
-16,200
Closed -$52K – 3672
2020
Q1 		$52K Buy
+16,200
New +$86.3K ﹤0.01% 2926

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments's RVLP Position: Q3 2022 in Review

Two Sigma Investments sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2022, closing a stake of 22,413 shares — an estimated $30K sold.

Two Sigma Investments first reported a position in RVLP in Q1 2020 and held it in 4 quarters. The position peaked at $270K in Q4 2021. 46 funds tracked by Wall St. Rank hold RVLP as of Q3 2022.

  • Two Sigma Investments reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Investments sold 22,413 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2022, an estimated $30K.
  • Two Sigma Investments first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2020 and held it in 4 quarters.
  • Two Sigma Investments's RVL Pharmaceuticals plc Ordinary Shares position peaked at $270K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.